Dr. Nicoleta Moisoi is a committed scientist with more than 10 years of experience in leading UK and European research institutes, working on signaling mechanisms implicated in neurodegeneration, and genetic and pharmacologic disease intervention.
Dr. Moisoi earned her PhD in biophysics at the University of Bucharest, Romania. She went on to undertake post-doctoral research at NIMR-MRC in London, UK and at the MRC Toxicology Unit and University of Leicester in Leicester, UK. She joined De Montfort University in the Leicester School of Pharmacy in 2016. Honors and awards throughout her career include Junior Associate of ICTP (Italy) and Royal Society/NATO Fellowship (UK).
Her studies address mitochondrial homeostasis and its implication in aging and parkinsonism, and signaling mechanisms involved in cell death and cell survival. Her recent work focuses on mitochondria quality control signaling and the identification and validation of novel druggable pathways in Parkinson’s disease.
Associated Grants
-
Enhancing Mitochondria Quality Control in Parkinson’s via Activation of the Caseinolytic Peptidase
2015